Search results
Found 13 matches for
We recently worked with Mediaplanet on the 2019 Health Awareness: Value of Vaccines campaign. The campaign features exclusive content from key thought leaders and industry voices about the critical importance of full immunisation throughout life.
Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines
Paediatrics
26 October 2023
This study will test the responses of cells in lymph nodes before and after immunisation with flu and COVID-19 vaccines and compare reactions in older and younger adults
Study raises hope of pre-school type 1 diabetes screening programme
Paediatrics
6 September 2022
Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.
Promising Marburg vaccine yet to be tested on humans due to lack of funding
Paediatrics
1 August 2022
Oxford University’s Professor Teresa Lambe, the designer of the vaccine, fears Marburg disease is ‘now being seen in places where it’s never been seen before’
Early life infection increases sensitivity to pain in newborn babies
Paediatrics
14 July 2022
Researchers from Oxford’s Department of Paediatrics have discovered that infection can increase a baby’s sensitivity to pain, which may last longer than the infection.
Oxford expands the Cartography collaboration with Janssen
NDM Paediatrics
6 June 2022
The University of Oxford announced today that it has expanded a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation
Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment
Paediatrics
16 May 2022
A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.
Oxford scientist named Australian of the Year in the UK
Jenner Paediatrics
29 April 2022
The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.
Typhoid vaccine over 81% effective in tackling disease in Nepal
Paediatrics
5 December 2019
A large field study of typhoid conjugate vaccine (TCV) in Nepal has shown a single dose to be safe and effective in reducing typhoid in children aged 9 months to <16 years in an endemic setting.
International neglect of typhoid outside rich countries threatens a new global health emergency
Paediatrics
7 November 2019
The emergence of untreatable strains of typhoid threatens a new global health emergency that requires urgent collective action, argue experts from the Oxford Martin School in the journal Clinical Infectious Diseases today.
Is mandatory vaccination the best way to tackle falling rates of childhood immunisation?
Paediatrics
28 October 2019
Following the publication of figures showing UK childhood vaccination rates have fallen for the fifth year in a row, researchers from OVG and the Oxford Martin Programme on Collective Responsibility for Infectious Disease discuss possible responses.
The global value of vaccination
Paediatrics
27 June 2019
We recently worked with Mediaplanet on the 2019 Health Awareness: Value of Vaccines campaign. The campaign features exclusive content from key thought leaders and industry voices about the critical importance of full immunisation throughout life.
Halting the spread of salmonella
Paediatrics
12 October 2018
There are between 11 and 27 million estimated cases of enteric fever worldwide every year, and 75,000–220,000 deaths. Could vaccination stop the spread of these diesases in the environment?
Vaccinations and the fight against poverty
Paediatrics
31 July 2018
What does it mean to be poor in the UK and around the world? Could we eliminate this kind of inequality or is it an unavoidable part of society? This needs a lot more thought...